The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | Molecular profiling of esophagogastric cancer patient-derived xenografts
Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center, New York, NY, outlines the results of comprehensive molecular profiling of esophagogastric cancer patient-derived xenografts which were found to accurately recapitulate the genomic heterogeneity and tumor biology of patients with esophagogastric cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
